» Articles » PMID: 33779549

Disparate Bone Anabolic Cues Activate Bone Formation by Regulating the Rapid Lysosomal Degradation of Sclerostin Protein

Overview
Journal Elife
Specialty Biology
Date 2021 Mar 29
PMID 33779549
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The downregulation of sclerostin in osteocytes mediates bone formation in response to mechanical cues and parathyroid hormone (PTH). To date, the regulation of sclerostin has been attributed exclusively to the transcriptional downregulation of the gene hours after stimulation. Using mouse models and rodent cell lines, we describe the rapid, minute-scale post-translational degradation of sclerostin protein by the lysosome following mechanical load and PTH. We present a model, integrating both new and established mechanically and hormonally activated effectors into the regulated degradation of sclerostin by lysosomes. Using a mouse forelimb mechanical loading model, we find transient inhibition of lysosomal degradation or the upstream mechano-signaling pathway controlling sclerostin abundance impairs subsequent load-induced bone formation by preventing sclerostin degradation. We also link dysfunctional lysosomes to aberrant sclerostin regulation using human Gaucher disease iPSCs. These results reveal how bone anabolic cues post-translationally regulate sclerostin abundance in osteocytes to regulate bone formation.

Citing Articles

Melanoma bone metastasis-induced osteocyte ferroptosis via the HIF1α-HMOX1 axis.

Jia Y, Li R, Li Y, Kachler K, Meng X, Giessl A Bone Res. 2025; 13(1):9.

PMID: 39814705 PMC: 11735842. DOI: 10.1038/s41413-024-00384-y.


A proteomics approach to study mouse long bones: examining baseline differences and mechanical loading-induced bone formation in young-adult and old mice.

Chermside-Scabbo C, Shuster J, Erdmann-Gilmore P, Tycksen E, Zhang Q, Townsend R Aging (Albany NY). 2024; 16(19):12726-12768.

PMID: 39400554 PMC: 11501390. DOI: 10.18632/aging.206131.


Machine Learning-Driven Biomarker Discovery for Skeletal Complications in Type 1 Gaucher Disease Patients.

Cebolla J, Giraldo P, Gomez J, Montoto C, Gervas-Arruga J Int J Mol Sci. 2024; 25(16).

PMID: 39201273 PMC: 11354847. DOI: 10.3390/ijms25168586.


Osteocyte-mediated mechanical response controls osteoblast differentiation and function.

Buck H, Stains J Front Physiol. 2024; 15:1364694.

PMID: 38529481 PMC: 10961341. DOI: 10.3389/fphys.2024.1364694.


Controlled mechanical loading affects the osteocyte transcriptome in porcine trabecular bone in situ.

Machireddy M, Oberman A, DeBiase L, Stephens M, Li J, Littlepage L Bone. 2024; 181:117028.

PMID: 38309412 PMC: 10923013. DOI: 10.1016/j.bone.2024.117028.


References
1.
Spatz J, Wein M, Gooi J, Qu Y, Garr J, Liu S . The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro. J Biol Chem. 2015; 290(27):16744-58. PMC: 4505423. DOI: 10.1074/jbc.M114.628313. View

2.
Wein M . Parathyroid Hormone Signaling in Osteocytes. JBMR Plus. 2018; 2(1):22-30. PMC: 6124166. DOI: 10.1002/jbm4.10021. View

3.
Compston J . Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure. Bone. 2006; 40(6):1447-52. DOI: 10.1016/j.bone.2006.09.008. View

4.
Baik A, Qiu J, Hillman E, Dong C, Guo X . Simultaneous tracking of 3D actin and microtubule strains in individual MLO-Y4 osteocytes under oscillatory flow. Biochem Biophys Res Commun. 2013; 431(4):718-23. PMC: 3587714. DOI: 10.1016/j.bbrc.2013.01.052. View

5.
McClung M . Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential. Ther Adv Musculoskelet Dis. 2017; 9(10):263-270. PMC: 5613857. DOI: 10.1177/1759720X17726744. View